BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38603639)

  • 1. Shining a Light: Unveiling Cardiac Risks Using Positron Emission Tomography Imaging in Lung Cancer Radiotherapy.
    Finazzi T; Putora PM
    JCO Clin Cancer Inform; 2024 Apr; 8():e2400045. PubMed ID: 38603639
    [No Abstract]   [Full Text] [Related]  

  • 2. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.
    Akthar AS; Ferguson MK; Koshy M; Vigneswaran WT; Malik R
    Technol Cancer Res Treat; 2017 Feb; 16(1):15-21. PubMed ID: 26792491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia imaging using Positron Emission Tomography in non-small cell lung cancer: implications for radiotherapy.
    Bollineni VR; Wiegman EM; Pruim J; Groen HJ; Langendijk JA
    Cancer Treat Rev; 2012 Dec; 38(8):1027-32. PubMed ID: 22560366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET scans in radiotherapy planning of lung cancer.
    De Ruysscher D; Kirsch CM
    Radiother Oncol; 2010 Sep; 96(3):335-8. PubMed ID: 20656364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RTOG current clinical trials in lung cancer. Overview.
    Choy H
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):624-5. PubMed ID: 16167047
    [No Abstract]   [Full Text] [Related]  

  • 6. Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer?
    Ohba Y; Nomori H; Mori T; Ikeda K; Shibata H; Kobayashi H; Shiraishi S; Katahira K
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):439-45. PubMed ID: 19619793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and central photopenia detected by fluorine-18 fluoro-deoxy-glucose positron emission tomography (FDG-PET) in patients with locoregional non-small cell lung cancer treated with radiotherapy.
    Ashley Cox R; Akhurst T; Bressel M; MacManus M; Ball D
    Radiother Oncol; 2017 Jul; 124(1):25-30. PubMed ID: 28662870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should patient setup in lung cancer be based on the primary tumor? An analysis of tumor coverage and normal tissue dose using repeated positron emission tomography/computed tomography imaging.
    van Elmpt W; Öllers M; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):379-85. PubMed ID: 21093173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The impact of 18F-fluorodeoxyglucose positron emission tomography on the 3D conformal radiotherapy planning in patients with non-small cell lung cancer].
    Bachaud JM; Marre D; Dygai I; Caselles O; Hamelin D; Bègue M; Laprie A; Zerdoud S; Gancel M; Courbon F
    Cancer Radiother; 2005 Dec; 9(8):602-9. PubMed ID: 16316759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer.
    Shirvani SM; Komaki R; Heymach JV; Fossella FV; Chang JY
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e91-7. PubMed ID: 21489716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep inspiration breath hold radiotherapy for locally advanced lung cancer: comparison of different treatment techniques on target coverage, lung dose and treatment delivery time.
    Josipovic M; Persson GF; Håkansson K; Damkjær SM; Bangsgaard JP; Westman G; Riisgaard S; Specht L; Aznar MC
    Acta Oncol; 2013 Oct; 52(7):1582-6. PubMed ID: 24047341
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour metabolic activity measured by fluorodeoxyglucose positron emission tomography for radiotherapy planning as a prognostic factor for locally advanced non-small cell lung cancer.
    Masarykova A; Scepanovic D; Povinec P; Bires P; Lederleitner D; Pobijakova M
    Bratisl Lek Listy; 2018; 119(3):133-138. PubMed ID: 29536740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of dual-energy CT with positron emission tomography for lung perfusion imaging in patients with non-small cell lung cancer.
    Gaudreault M; Korte J; Bucknell N; Jackson P; Sakyanun P; McIntosh L; Woon B; Buteau JP; Hofman MS; Mulcahy T; Kron T; Siva S; Hardcastle N
    Phys Med Biol; 2023 Jan; 68(3):. PubMed ID: 36623318
    [No Abstract]   [Full Text] [Related]  

  • 14. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
    Vinod SK; Kumar S; Holloway LC; Shafiq J
    J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lung cancer and elective nodal irradiation: A solved issue?].
    Laurans M; Botticella A; Moukasse Y; Lévy A; Le Péchoux C
    Cancer Radiother; 2019 Oct; 23(6-7):701-707. PubMed ID: 31501024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
    Chin AL; Kumar KA; Guo HH; Maxim PG; Wakelee H; Neal JW; Diehn M; Loo BW; Gensheimer MF
    Clin Lung Cancer; 2018 Sep; 19(5):e581-e588. PubMed ID: 29759331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical Radiation for Large-Volume Locally Advanced Non-Small Cell Lung Cancer: Constrained by Constraints!
    Tsao MN; Louie AV
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):261-263. PubMed ID: 33989567
    [No Abstract]   [Full Text] [Related]  

  • 18. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?: in regard to Devic et al. (Int J Radiat Oncol Biol Phys 2010).
    Hatt M; Visvikis D
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1605. PubMed ID: 21092836
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advances in research on biological target volume and conformal intensity-modulated radiotherapy].
    Yu JM; Chen SQ
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):801-3. PubMed ID: 17415998
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.